IL179218A0 - Aerosol formulation for inhalation of beta agonists - Google Patents

Aerosol formulation for inhalation of beta agonists

Info

Publication number: IL179218A0
Authority: IL; Israel
Prior art keywords: inhalation; aerosol formulation; beta agonists; agonists; beta
Prior art date: 2004-05-14

Application number

IL179218A

Other versions

IL179218A (en

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-14

Filing date

2006-11-13

Publication date

2007-03-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL179218(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-11-13 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2007-03-08 Publication of IL179218A0 publication Critical patent/IL179218A0/en

2012-10-31 Publication of IL179218A publication Critical patent/IL179218A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Dispersion Chemistry (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

IL179218A 2004-05-14 2006-11-13 Aerosol formulation for inhalation of beta agonists IL179218A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004024452A DE102004024452A1 (en)	2004-05-14	2004-05-14	Aerosol formulation for the inhalation of beta agonists
PCT/EP2005/005028 WO2005110421A2 (en)	2004-05-14	2005-05-10	Aerosol formulation for inhalation of beta agonists

Publications (2)

Publication Number	Publication Date
IL179218A0 true IL179218A0 (en)	2007-03-08
IL179218A IL179218A (en)	2012-10-31

Family

ID=34979667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL179218A IL179218A (en)	2004-05-14	2006-11-13	Aerosol formulation for inhalation of beta agonists

Country Status (26)

Country	Link
EP (1)	EP1809293B1 (en)
JP (1)	JP4620730B2 (en)
KR (1)	KR101288791B1 (en)
CN (1)	CN101056640A (en)
AR (1)	AR049096A1 (en)
AU (1)	AU2005244414B2 (en)
BR (1)	BRPI0511135B8 (en)
CA (1)	CA2564379C (en)
DE (1)	DE102004024452A1 (en)
DK (1)	DK1809293T3 (en)
EA (1)	EA012583B1 (en)
EC (1)	ECSP067004A (en)
ES (1)	ES2575925T3 (en)
HU (1)	HUE027780T2 (en)
IL (1)	IL179218A (en)
MX (1)	MXPA06013216A (en)
MY (1)	MY148403A (en)
NO (1)	NO20065030L (en)
PE (1)	PE20060311A1 (en)
PL (1)	PL1809293T3 (en)
SG (1)	SG152265A1 (en)
TW (1)	TWI356703B (en)
UA (1)	UA87312C2 (en)
UY (1)	UY28891A1 (en)
WO (1)	WO2005110421A2 (en)
ZA (1)	ZA200607462B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DK1917253T3 (en)	2005-08-15	2015-03-30	Boehringer Ingelheim Int	Method of Preparation of Beta Mimetics
EP1948186A1 (en) *	2005-11-09	2008-07-30	Boehringer Ingelheim International Gmbh	Aerosolformulation for inhalation
UY30543A1 (en) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	AEROSOL FORMULATION FOR INHALATION OF BETA- AGONISTS
WO2010057927A1 (en) *	2008-11-21	2010-05-27	Boehringer Ingelheim International Gmbh	Aerosol formulation for the inhalation of beta agonists
JP2012509299A (en) *	2008-11-21	2012-04-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Aerosol formulation for inhalation of beta agonist
JP2015533131A (en)	2012-10-09	2015-11-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Beta2-adrenergic receptor agonists for treating cough
US20200069679A1 (en)	2016-12-12	2020-03-05	Boehringer Ingelheim International Gmbh	Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with oladaterol
US20230095589A1 (en) *	2019-12-05	2023-03-30	Syngenta Crop Protection Ag	One step process for the preparation of phenyl ethyl amine derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3134590A1 (en) *	1981-09-01	1983-03-10	Boehringer Ingelheim KG, 6507 Ingelheim	NEW BENZO HETEROCYCLES
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (en) *	1986-02-17	1994-05-18	千寿製薬株式会社	Aqueous solution
GB9405019D0 (en) *	1994-03-15	1994-04-27	Smithkline Beecham Plc	Novel compounds
DE10253282A1 (en) *	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration
DE102004019539A1 (en) *	2004-04-22	2005-11-10	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drugs for the treatment of respiratory diseases
NZ550797A (en) *	2004-04-22	2010-08-27	Boehringer Ingelheim Int	Pharmaceutical combinations containing 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethylethylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one for treating respiratory diseases
DE102004024454A1 (en) *	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals
DE102004024451A1 (en) *	2004-05-14	2005-12-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Powder formulations for inhalation containing enantiomerically pure beta agonists

2004
- 2004-05-14 DE DE102004024452A patent/DE102004024452A1/en not_active Withdrawn
2005
- 2005-05-10 CA CA2564379A patent/CA2564379C/en not_active Expired - Lifetime
- 2005-05-10 DK DK05747843.0T patent/DK1809293T3/en active
- 2005-05-10 HU HUE05747843A patent/HUE027780T2/en unknown
- 2005-05-10 KR KR1020067026225A patent/KR101288791B1/en not_active Expired - Lifetime
- 2005-05-10 MX MXPA06013216A patent/MXPA06013216A/en active IP Right Grant
- 2005-05-10 JP JP2007512068A patent/JP4620730B2/en not_active Expired - Lifetime
- 2005-05-10 EP EP05747843.0A patent/EP1809293B1/en not_active Expired - Lifetime
- 2005-05-10 ES ES05747843.0T patent/ES2575925T3/en not_active Expired - Lifetime
- 2005-05-10 EA EA200602017A patent/EA012583B1/en not_active IP Right Cessation
- 2005-05-10 UA UAA200612949A patent/UA87312C2/en unknown
- 2005-05-10 AU AU2005244414A patent/AU2005244414B2/en not_active Expired
- 2005-05-10 CN CNA2005800154865A patent/CN101056640A/en active Pending
- 2005-05-10 WO PCT/EP2005/005028 patent/WO2005110421A2/en not_active Ceased
- 2005-05-10 SG SG200902777-2A patent/SG152265A1/en unknown
- 2005-05-10 PL PL05747843.0T patent/PL1809293T3/en unknown
- 2005-05-10 BR BRPI0511135A patent/BRPI0511135B8/en active IP Right Grant
- 2005-05-11 UY UY28891A patent/UY28891A1/en not_active Application Discontinuation
- 2005-05-12 MY MYPI20052158A patent/MY148403A/en unknown
- 2005-05-12 PE PE2005000529A patent/PE20060311A1/en not_active Application Discontinuation
- 2005-05-13 AR ARP050101959A patent/AR049096A1/en unknown
- 2005-05-13 TW TW094115491A patent/TWI356703B/en not_active IP Right Cessation
2006
- 2006-09-06 ZA ZA200607462A patent/ZA200607462B/en unknown
- 2006-11-02 NO NO20065030A patent/NO20065030L/en not_active Application Discontinuation
- 2006-11-13 IL IL179218A patent/IL179218A/en active IP Right Grant
- 2006-11-13 EC EC2006007004A patent/ECSP067004A/en unknown

Also Published As

Publication number	Publication date
ES2575925T3 (en)	2016-07-04
PE20060311A1 (en)	2006-05-08
IL179218A (en)	2012-10-31
CA2564379A1 (en)	2005-11-24
CN101056640A (en)	2007-10-17
EA200602017A1 (en)	2007-06-29
JP4620730B2 (en)	2011-01-26
DE102004024452A1 (en)	2005-12-08
PL1809293T3 (en)	2016-09-30
BRPI0511135B1 (en)	2019-11-12
UY28891A1 (en)	2005-12-30
CA2564379C (en)	2013-07-30
ECSP067004A (en)	2007-02-28
MXPA06013216A (en)	2007-02-08
NO20065030L (en)	2006-11-30
HUE027780T2 (en)	2016-11-28
AU2005244414A1 (en)	2005-11-24
ZA200607462B (en)	2008-06-25
SG152265A1 (en)	2009-05-29
KR20070022084A (en)	2007-02-23
WO2005110421A3 (en)	2006-03-16
TW200608981A (en)	2006-03-16
BRPI0511135B8 (en)	2021-05-25
UA87312C2 (en)	2009-07-10
JP2007537188A (en)	2007-12-20
EA012583B1 (en)	2009-10-30
EP1809293B1 (en)	2016-03-16
BRPI0511135A (en)	2007-11-27
AU2005244414B2 (en)	2010-12-09
WO2005110421A2 (en)	2005-11-24
DK1809293T3 (en)	2016-06-20
AR049096A1 (en)	2006-06-28
EP1809293A2 (en)	2007-07-25
KR101288791B1 (en)	2013-07-29
MY148403A (en)	2013-04-30
TWI356703B (en)	2012-01-21

Publication	Publication Date	Title
IL190682A0 (en)	2008-11-03	Aerosol formulation for the inhalation of beta agonists
IL197025A0 (en)	2009-11-18	Aerosol formulation for the inhalation of beta agonists
IL197024A0 (en)	2009-11-18	Aerosol formulation for the inhalation of beta agonists
ZA200804654B (en)	2014-07-30	Powder compositions for inhalation
SI1670472T1 (en)	2008-06-30	Aerosol formulation for inhalation, containing an anticholinergic agent
EP1993646A4 (en)	2012-07-04	Nozzle pore configuration for intrapulmonary delivery of aerosolized formulations
PL1727434T3 (en)	2013-04-30	Delivery of functional ingredients
ZA200903840B (en)	2010-03-31	Powder formulation for valganciclovir
GB0416328D0 (en)	2004-08-25	Use of dry powder compositions for pulmonary delivery
IL183930A0 (en)	2007-10-31	Use of cladribine for preparation of pharmaceutical compositions
ZA200807486B (en)	2009-11-25	Medicament formulations comprising fluoroquinolones
ZA200806929B (en)	2009-11-25	Nebulizer formulation
IL179218A0 (en)	2007-03-08	Aerosol formulation for inhalation of beta agonists
EP1806148A4 (en)	2009-12-02	Medicinal composition for inhalation
DK1809236T3 (en)	2013-02-11	Powder formulations for inhalation containing enatiomerically pure beta agonists
PT1496876E (en)	2008-04-15	Aerosol formulation for inhalation comprising tiotropiumbromide
ZA200900370B (en)	2010-01-27	Aerosol formulation for the inhalation of beta agonists
ATE401861T1 (en)	2008-08-15	POWDER FORMULATION CONTAINING TIOTROPIUM FOR INHALATION
PT2167042E (en)	2015-12-21	Pharmaceutical aerosol compositions comprising fluticasone
PL2094240T3 (en)	2018-03-30	Stable powder formulation containing a new antichinolinergic agent
GB0501956D0 (en)	2005-03-09	Nebulizer formulation
ZA200900418B (en)	2009-11-25	Aerosol formulation for the inhalation of beta agonists
GB2451360B (en)	2011-10-05	Hormone replacement formulation
AP2006003734A0 (en)	2006-10-31	Inhalation formulation
ZA200606181B (en)	2007-10-31	Aerosol formulation

Legal Events

Date	Code	Title
2013-02-28	FF	Patent granted
2013-03-24	KB	Patent renewed
2015-04-30	KB	Patent renewed
2019-05-30	KB	Patent renewed